triamcinolone acetonide has been researched along with Genital Neoplasms, Male in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norris, JS; Smith, RG; Syms, AJ | 1 |
| Harris, SE; Malark, M; Mansson, PE; Smith, RG; Zhou, H | 1 |
2 other study(ies) available for triamcinolone acetonide and Genital Neoplasms, Male
| Article | Year |
|---|---|
Differential effects of androgens and glucocorticoids on regulation of androgen receptor concentrations and cell growth.
Topics: Androgens; Animals; Cell Division; Cell Line; Centrifugation, Density Gradient; Cricetinae; Dihydrotestosterone; Flow Cytometry; Genital Neoplasms, Male; Glucocorticoids; Male; Receptors, Androgen; Receptors, Steroid; Triamcinolone Acetonide; Vas Deferens | 1984 |
Androgens and glucocorticoids modulate heparin-binding growth factor I mRNA accumulation in DDT1 cells as analyzed by in situ hybridization.
Topics: Animals; Cell Line; Cricetinae; Fibroblast Growth Factor 1; Fibroblast Growth Factors; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Male; Growth Substances; Heparin; Leiomyosarcoma; Male; Mesocricetus; RNA, Messenger; RNA, Neoplasm; Testosterone; Triamcinolone Acetonide; Vas Deferens | 1989 |